Literature DB >> 27625433

Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Sara Gianella1, Scott Letendre1.   

Abstract

Human immunodeficiency virus (HIV)-infected adults who take stable antiretroviral therapy (ART) are at risk for early onset of age-related diseases. This is likely due to a complex interaction between traditional risk factors, HIV infection itself, and other factors, such as underlying immune dysfunction and persistent inflammation. HIV disrupts the balance between the host and coinfecting microbes, worsening control of these potential pathogens. For example, HIV-infected adults are more likely than the general population to have subclinical bursts of cytomegalovirus (CMV) replication at mucosal sites. Production of antigens can activate the immune system and stimulate HIV replication, and it could contribute to the pathogenesis of adverse outcomes of aging, like cardiovascular disease and neurocognitive impairment. Further investigation of the relationships between CMV, immune dysfunction, and unsuccessful aging during chronic HIV infection is warranted.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  HIV; aging; cytomegalovirus; end organ disease; immune dysfunction; inflammation

Mesh:

Year:  2016        PMID: 27625433      PMCID: PMC5021239          DOI: 10.1093/infdis/jiw217

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  115 in total

1.  CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

Authors:  M A Suni; S A Ghanekar; D W Houck; H T Maecker; S B Wormsley; L J Picker; R B Moss; V C Maino
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

Review 2.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease.

Authors:  W R Lin; D Shang; R F Itzhaki
Journal:  Mol Chem Neuropathol       Date:  1996 May-Aug

4.  Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA.

Authors:  Sara Gianella; Christy M Anderson; Milenka V Vargas; Douglas D Richman; Susan J Little; Sheldon R Morris; Davey M Smith
Journal:  J Infect Dis       Date:  2012-12-28       Impact factor: 5.226

Review 5.  The end of AIDS: HIV infection as a chronic disease.

Authors:  Steven G Deeks; Sharon R Lewin; Diane V Havlir
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

6.  Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

Authors:  E J Wright; B Grund; K Robertson; B J Brew; M Roediger; M P Bain; F Drummond; M J Vjecha; J Hoy; C Miller; A C Penalva de Oliveira; W Pumpradit; J C Shlay; W El-Sadr; R W Price
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

7.  Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.

Authors:  J B Muhlestein; B D Horne; J F Carlquist; T E Madsen; T L Bair; R R Pearson; J L Anderson
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

Review 8.  Residual inflammation and viral reservoirs: alliance against an HIV cure.

Authors:  Marta Massanella; Rémi Fromentin; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

9.  Immune senescence: relative contributions of age and cytomegalovirus infection.

Authors:  Andrea Mekker; Vincent S Tchang; Lea Haeberli; Annette Oxenius; Alexandra Trkola; Urs Karrer
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

10.  CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals.

Authors:  Alejandra Pera; Carmen Campos; Alonso Corona; Beatriz Sanchez-Correa; Raquel Tarazona; Anis Larbi; Rafael Solana
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  56 in total

1.  Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa.

Authors:  Stanzi M le Roux; Kirsten A Donald; Kirsty Brittain; Tamsin K Phillips; Allison Zerbe; Kelly K Nguyen; Andrea Strandvik; Max Kroon; Elaine J Abrams; Landon Myer
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

2.  Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.

Authors:  Stephen R Morris; Bonnie Chen; Joseph C Mudd; Soumya Panigrahi; Carey L Shive; Scott F Sieg; Cheryl M Cameron; David A Zidar; Nicholas T Funderburg; Souheil-Antoine Younes; Benigno Rodriguez; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  JCI Insight       Date:  2020-06-04

Review 3.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

4.  Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells.

Authors:  Adriana Tovar-Salazar; Adriana Weinberg
Journal:  Virology       Date:  2020-05-10       Impact factor: 3.616

5.  Cytomegalovirus-induced pathology in human temporal bones with congenital and acquired infection.

Authors:  Vladimir Tsuprun; Nevra Keskin; Mark R Schleiss; Pat Schachern; Sebahattin Cureoglu
Journal:  Am J Otolaryngol       Date:  2019-08-02       Impact factor: 1.808

6.  Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.

Authors:  Scott Letendre; Ajay Bharti; Ignacio Perez-Valero; Barbara Hanson; Donald Franklin; Steven Paul Woods; Sara Gianella; Michelli Faria de Oliveira; Robert K Heaton; Igor Grant; Alan L Landay; Nell Lurain
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

7.  Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.

Authors:  Eshan U Patel; Sara Gianella; Kevin Newell; Aaron A R Tobian; Allison R Kirkpatrick; Fredrick Nalugoda; Mary K Grabowski; Ronald H Gray; David Serwadda; Thomas C Quinn; Andrew D Redd; Steven J Reynolds
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

8.  Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Authors:  Sara Gianella; Antoine Chaillon; Ece A Mutlu; Phillip A Engen; Robin M Voigt; Ali Keshavarzian; John Losurdo; Prachi Chakradeo; Steven M Lada; Masato Nakazawa; Alan L Landay
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

9.  Cytomegalovirus Coinfection Is Associated with Increased Vascular-Homing CD57+ CD4 T Cells in HIV Infection.

Authors:  Bonnie Chen; Stephen R Morris; Soumya Panigrahi; Gillian M Michaelson; Jonathan M Wyrick; Alexey A Komissarov; Daria Potashnikova; Anna Lebedeva; Souheil-Antoine Younes; Karem Harth; Vikram S Kashyap; Elena Vasilieva; Leonid Margolis; David A Zidar; Scott F Sieg; Carey L Shive; Nicholas T Funderburg; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  J Immunol       Date:  2020-03-30       Impact factor: 5.422

10.  Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.

Authors:  Caleb Skipper; Mark R Schleiss; Ananta S Bangdiwala; Nelmary Hernandez-Alvarado; Kabanda Taseera; Henry W Nabeta; Abdu K Musubire; Sarah M Lofgren; Darin L Wiesner; Joshua Rhein; Radha Rajasingham; Charlotte Schutz; Graeme Meintjes; Conrad Muzoora; David B Meya; David R Boulware
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.